Amyris Inc (AMRS)

0.53
0.01 0.95
NASDAQ : Basic Materials
Prev Close 0.53
Open 0.52
Day Low/High 0.52 / 0.54
52 Wk Low/High 0.31 / 2.57
Volume 411.53K
Avg Volume 2.34M
Exchange NASDAQ
Shares Outstanding 235.02M
Market Cap 115.16M
EPS -1.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Amyris In Partnership With Boticario Group Named Gold Winner By Cosmetics Design For Breakthrough Ingredient - Neossance® Hemisqualane

Amyris In Partnership With Boticario Group Named Gold Winner By Cosmetics Design For Breakthrough Ingredient - Neossance® Hemisqualane

Industry Recognition of Neossance and Accelerated Customer Adoption Continues to Fuel Record Sales Growth

Amyris Wins Three-Year, Multi-Million-Dollar Contract From U.S. Department Of Energy To Further Manufacturing Of Cellulose-Derived Farnesene

Amyris Wins Three-Year, Multi-Million-Dollar Contract From U.S. Department Of Energy To Further Manufacturing Of Cellulose-Derived Farnesene

Expected to Expand Global Availability of Farnesene for Variety of Applications

Amyris Reports Second Quarter 2016 Results

Amyris Reports Second Quarter 2016 Results

Strongest Operational Execution to Date while Successfully Moving the Business Beyond Biofuels

American Refining Group Invests In Novvi To Accelerate Amyris Commercialization Of Renewable Base Oil And Lubricant Platform

American Refining Group Invests In Novvi To Accelerate Amyris Commercialization Of Renewable Base Oil And Lubricant Platform

ARG Joins Amyris and Cosan with Equity Investment and Market Access to Accelerate Revenue Growth of Novvi High Performance, Sustainably Sourced, Renewable Lubricant Products

Demand for Aviation Biofuels Grows as Green Regulations Loom

But in a narrow field, finding suppliers may be an issue.

Amyris Fuels First Delivery Of New Airbus A350-900 Airplane For Cathay Pacific As Part Of Two-Year Biojet Agreement

Amyris Fuels First Delivery Of New Airbus A350-900 Airplane For Cathay Pacific As Part Of Two-Year Biojet Agreement

Two Year Committed Jet Fuel Supply Deal Demonstrating Continued Strong Farnesene Demand

Gen9 And Amyris Announce Supply Agreement For Synthetic DNA

Gen9 And Amyris Announce Supply Agreement For Synthetic DNA

Gen9 and Amyris today announced an agreement for the supply of multiple megabases of synthetic DNA content.

7 Stocks Under $10 to Trade for Big Profits

7 Stocks Under $10 to Trade for Big Profits

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Amyris Signs Five Year Biofene® Supply Agreement With Leading Global Nutraceuticals Company With Over $100 Million Of Expected Value

Amyris Signs Five Year Biofene® Supply Agreement With Leading Global Nutraceuticals Company With Over $100 Million Of Expected Value

Provides Secure Supply for Highly Disruptive Nutraceutical Product

Amyris Named Gold 2016 Edison Award Winner -- One Of Highest Accolades For Innovation In Business

Amyris Named Gold 2016 Edison Award Winner -- One Of Highest Accolades For Innovation In Business

Recognized in Diagnostics & Disease Treatment Category Showcasing BioPharma Collaborative Excellence